Link opens in a new tab
opens in new window
Jennifer is a recognized leader within Deloitte’s NextGen Therapy practice and serves as co-lead of the NextGen Therapies Industry Working Group (IWG). The IWG functions as a dynamic, cross-functional forum that brings together industry leaders to foster collaboration, share innovative ideas, and advance the future of therapies for patients, their families, and the NextGen community.
With more than 25 years of clinical experience, Jennifer brings deep expertise and a practitioner’s perspective to her consulting work. Having spent the majority of her career in Oncology with a specialization in bone marrow transplantation, Jennifer has an intimate understanding of the challenges patients, families, and clinicians face. She leverages this frontline experience to address complex industry obstacles, champion the removal of barriers to care, and drive harmonization efforts across the healthcare ecosystem. Through her leadership at Deloitte, Jennifer is dedicated to improving patient outcomes and shaping the future of next-generation therapies.